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Abstract: The pathogenic clostridia cause many human and animal diseases, which typically
arise as a consequence of the production of potent exotoxins. Among the enterotoxic clostridia,
Clostridium difficile is the main causative agent of nosocomial intestinal infections in adults with a
compromised gut microbiota caused by antibiotic treatment. The symptoms of C. difficile infection
are essentially caused by the production of two exotoxins: TcdA and TcdB. Moreover, for severe
forms of disease, the spectrum of diseases caused by C. difficile has also been correlated to the levels
of toxins that are produced during host infection. This observation strengthened the idea that the
regulation of toxin synthesis is an important part of C. difficile pathogenesis. This review summarizes
our current knowledge about the regulators and sigma factors that have been reported to control toxin
gene expression in response to several environmental signals and stresses, including the availability
of certain carbon sources and amino acids, or to signaling molecules, such as the autoinducing
peptides of quorum sensing systems. The overlapping regulation of key metabolic pathways and
toxin synthesis strongly suggests that toxin production is a complex response that is triggered by
bacteria in response to particular states of nutrient availability during infection.
Keywords: C. difficile; PaLoc; toxin regulation; stress signals; carbon catabolite repression system;
growth phase; sporulation; c-di-GMP; quorum sensing
1. Introduction
The genus Clostridium comprises a vast and heterogeneous group of rod-shaped, spore-forming,
Gram-positive and obligate anaerobic bacteria [1]. Members of this genus are widespread in the
environment, and the majority of species are considered to be saprophytic, while some species
are pathogenic and responsible for a wide spectrum of diseases in both humans and animals.
The pathogenic clostridia cause a variety of neurotoxic, histotoxic and enterotoxic diseases, which
are associated with the production of potent exotoxins in most cases [2]. Among the enteric
clostridia, Clostridium difficile (recently renamed Peptoclostridium difficile [3]) is the major cause of
nosocomial diarrhea in adults with a compromised gut microbiota caused by the use of broad-spectrum
antibiotics [4]. The symptoms of C. difficile-associated disease range from mild diarrhea to severe
life-threatening pseudo-membranous colitis and toxic megacolon associated with high mortality
rates [5]. These symptoms are essentially caused by the production of two exotoxins: TcdA and
TcdB. These toxins glycosylate Rho family GTPases in host cells, leading to the disruption of the
actin cytoskeleton, cell death and a strong inflammatory response [6]. Toxins A and B are both
members of the large clostridial toxins (LCT) family, which includes the lethal and hemorrhagic
toxins (TcsL and TcsH, respectively) of Clostridium sordellii, the α toxin (TcnA) of Clostridium novyi
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and TpeL from Clostridium perfringens isolates from domestic livestock [7]. In addition, approximately
20% of C. difficile isolates obtained in non-outbreak situations [8] also produce a third toxin that
is named binary toxin (CDT) [9]. This toxin consists of two polypeptides: a binding component,
CDTb, responsible for attachment of the toxin complex to the host cell surface [10] and the active
component, CDTa that displays an actin-specific ADP-ribosyltransferase activity. The C. difficile CDT is
closely related to the iota toxin from C. perfringens type E, CST binary toxin from Clostridium spiroforme
and C2 toxin from Clostridium botulinum [11] The role of CDT in the disease process is still a matter
of debate since many virulent strains do not produce CDT. However, it has been shown that CDT
depolymerizes the actin cytoskeleton and at low doses, enhances the adhesion of C. difficile cells to the
gastrointestinal epithelium by inducing the formation of microtubule-based protrusions in the host
cell membranes [12–14]. Therefore, CDT might potentialize the toxicity of TcdA and TcdB and lead to
more severe disease, which would be consistent with the correlation between the presence of binary
toxin and the severe outcomes of CDI [9].
C. difficile infection (CDI) is a multi-step process that includes the disruption of the normal colonic
microflora, the germination and outgrowth of spores (of endogenous or exogenous origin) and the
subsequent colonization of the intestinal tract. During this process, vegetative cells multiply and
produce both Toxin A and Toxin B, causing clinical manifestations, followed by the dissemination
of spores. The spectrum of diseases caused by C. difficile was long thought to be related in part
to the potential of strains to produce variable levels of toxins. Since that time, Akerlund’s group
showed that toxin levels were correlated with the severity of C. difficile infection [15], confirming the
existence of a relationship between the symptoms of C. difficile-associated diarrhea (CDAD) and the
type and toxigenic potential of C. difficile strains [16]. In the early 2000s, this idea was reinforced
by the emergence of the epidemic and hypervirulent C. difficile strain NAPI/027 [17,18], which was
responsible for a massive increase in CDAD incidence and associated death. The major characteristic
of this strain is that it produces larger amounts of toxins A and B than non-epidemic strains. Taken
together, these observations strengthened the importance of the regulation of toxin synthesis for the
pathogenicity of C. difficile. It is now well established that the levels of toxin production are influenced
by growth conditions [19,20] and many environmental changes. One of the most important groups of
environmental cues that influences toxin production is likely to be nutritional signals. For instance,
limited concentrations of biotin or high levels of short-chain fatty acids in the medium increase toxin
production [21], while rapidly metabolizable sugars, or certain amino acids, greatly reduce toxin
yields [19,22–26]. Toxin production is also regulated by temperature, with an optimal temperature of
37 ˝C [27]. In addition, the impact of sub-inhibitory levels of antibiotics on toxin synthesis in C. difficile
has also been widely investigated. Certain antibiotics appear to increase toxin production, but the
specific response to an antibiotic appears to greatly vary from one strain to another [28–34].
To date, several regulation pathways that control toxin gene expression in response to several
environmental and nutritional signals have been identified. In particular, the expression of the major
virulence factors of C. difficile is under the control of a panel of nutrient-sensing regulators, suggesting
that the regulation of toxin production must be an essential part of the adaptive strategies that are
used by the bacteria in response to the environmental status encountered by C. difficile during infection.
This review summarizes our current understanding of the signals and the mechanisms that regulate
toxin synthesis in C. difficile.
2. The Pathogenicity Loci of C. difficile (PaLoc and CdtLoc)
One breakthrough in the understanding of the mechanism of toxin gene regulation originated
from the molecular analysis of a 19.6 kb chromosomal region that is known as the pathogenicity locus
(PaLoc) and is found only in toxigenic strains of C. difficile [35]. In addition to the genes that encode
toxin A (tcdA) and toxin B (tcdB), the PaLoc contains three accessory genes: tcdR and tcdC, which
encode proteins involved in the transcriptional regulation of the toxin genes [36,37], and tcdE, whose
product is required for the efficient secretion of TcdA and TcdB [38] (Figure 1A). For the majority
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of strains, the PaLoc is found in the same genomic location and is replaced in non-toxigenic strains
by a highly conserved 115/75 bp non-coding region [35,39]. However, it was recently shown that
the PaLoc can be integrated in different genomic locations that are distant from the classical PaLoc
integration site [40,41]. The presence of the PaLoc at different sites in the C. difficile genome suggested
that the PaLoc was likely acquired by horizontal transfer, even if the PaLoc is not an independent
mobile genetic element [35]. This hypothesis was supported by the G + C content of the PaLoc, which
differs from that of the genome as a whole, and by the ability of the Paloc to be transferred to a
non-toxigenic strain by a conjugation-like mechanism [42]. The recent identification of PaLoc-like
regions in C. sordellii [43] and C. perfringens [44] that contain the LCT-encoding genes and tcdR- and
tcdE-like genes supports the hypothesis that the LCT genes are located within PaLoc-related loci in
multiple Clostridium species (Figure 1A).
A transcriptional analysis of the PaLoc indicated that the first four genes of the locus (tcdR, tcdB,
tcdE and tcdA) are coordinately expressed when the cells approach stationary phase [20]. At this stage,
the levels of tcdA mRNA are approximately two-fold higher than those of tcdB [19], which is consistent
with larger amounts of TcdA being obtained after toxin purification [45]. Although tcdA and tcdB are
transcribed primarily from their own promoters (see below), they can be found on a polycistronic
transcript that is transcribed from a promoter identified >200 bp upstream of tcdR ORF [19,20,46].
CDT is encoded by two genes, cdtA and cdtB, which are transcriptionally linked and are located
on the C. difficile chromosome in an operon at a locus called the CDT locus (CdtLoc) separate from
the PaLoc. In most C. difficile strains that do not produce CDT, the CdtLoc is replaced by a 68-bp
non-coding region. In contrast to the regulation of the PaLoc genes (see below), very little research
has been carried out to understand how CdtLoc is regulated. However, the 6.2 kb CdtLoc includes a
response regulator gene cdtR, located upstream the cdt operon. Carter et al. have shown that CdtR, a
LytTR family response regulator, is able to activate CDT production [47]. This activation is likely direct
since they have recently demonstrated the binding of purified CdtR to the upstream cdtA promoter
region [48]. Further studies should focus on the nature of the unknown environmental or growth
phase signals and on the histidine kinase sensor involved in the CdtR activation through the transfer
of the phosphoryl group. Similar to the PaLoc, there is no evidence of transposon-, plasmid-, or
bacteriophage-related genes in close proximity to the CdtLoc.
3. Toxin A and B Genes Are Specifically Transcribed by an Alternative Sigma Factor
The tcdR gene, which lies upstream of tcdB in the PaLoc, encodes a small basic protein of
22 kDa [35], which contains a C-terminal helix-turn-helix DNA-binding motif [36]. The first evidence
for the role of TcdR in C. difficile toxin regulation was reported by Moncrief et al. [49]. Those authors
successfully activated tcdA and tcdB reporter fusions by expressing tcdR in trans in Escherichia coli [49].
These results were confirmed in similar experiments that used C. perfringens [36] as a surrogate host
and later in C. difficile [50]. Then, Mani and Dupuy provided genetic and biochemical evidence that
TcdR is required for the initiation of toxin gene transcription as a σ factor of the RNA polymerase
(RNAP) [36]. Indeed, TcdR is unable to bind alone to the toxin promoter regions but actually directs the
RNAP core enzyme to specifically recognize promoters and transcribe toxin genes [36]. Interestingly,
the promoter regions of tcdA and tcdB that show strong similarities to each other [19] do not resemble
the canonical σ70 promoter of prokaryotes, which is consistent with the use of a specific σ factor,
namely TcdR, for the transcription of toxin genes. In addition, TcdR also activates its own expression,
which is consistent with the presence of two potential promoters for TcdR-dependent transcription in
the region upstream of the tcdR gene [50].
TcdR is part of a new sub-group of the σ70 family that also includes other alternative σ factors of
pathogenic clostridia that are required for the transcription of genes that encode the botulinum and
tetanus neurotoxins (BotR and TetR, respectively [51]), the bacteriocin and cytotoxin of C. perfringens
(UviA and TpeR, respectively [44,52]) and the lethal and hemorrhagic toxins of C. sordellii (TcsR [43])
(Figure 1A). In addition, all of the promoters of the genes encoding these toxins and bacteriocin share a
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high degree of sequence similarity with the C. difficile toxin gene promoters (Figure 1B) [52]. Many of
the properties of these clostridial σ factors are similar to those of members of the extracytoplasmic
function (ECF) σ factors (group IV of the σ70-family), but they differ enough in structure and function
that they have been assigned to their own group (group V) [53]. Indeed, most of these TcdR-related σ
factors are functionally interchangeable with each other but not with members of other sub-groups
of the σ70 family [43,44,52]. Interestingly, these σ factors are encoded within genetic elements that
were probably acquired by horizontal gene transfer; UviA, TetR, TcsR and TpeR are encoded on
plasmids [44,54–57], TcdR is encoded within a PaLoc for which the presence of a putative holin and
a phage-like endolysin fragment [58] suggest a bacteriophage origin [35] and BotR is encoded in
bacteriophage genomes in some toxinotypes of C. botulinum [59]. In most cases, the genes that encode
these σ factors are located immediately upstream of the promoters of toxin and bacteriocin genes
and are transcribed in the same direction (Figure 1A). Moreover, in all examined cases, the σ gene is
autoregulated [50,51,60] and induced by one or several environmental signals [19,27,44,50] (see below).
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purple; (B). Sequence alignment of the promoter regions of the toxin and bacteriocin genes. The −35 
and −10 regions are based on determination of the transcriptional start sites [19,51,55,61,62]. The −35 
box is highly conserved in promoters of all genes while the −10 box possesses greater variations. 
4. Toxin Gene Transcription Is Negatively Controlled by TcdC 
The inverse timing of the expression of tcdC and the other PaLoc genes [20] has long suggested 
that TcdC could play a negative role in toxin gene expression. Moreover, the emergence of epidemic 
strains that produce high levels of both toxins and carry deletions or frameshift mutations in the tcdC 
Figure 1. Toxin and bacteriocin loci regulated by the TcdR-family of σ factors in the pathogenic
clostridia. (A). Genetic organization of clostridial toxin and bacteriocin encoding genes. Similarly
colored genes encode functionally related proteins: large clostridial toxins in grey, neurotoxins in green,
TcdR family alternative sigma factors in blue, holin-like proteins in orange and bacteriocin in purple;
(B). Sequence alignment of the promoter regions of the toxin and bacteriocin genes. The ´35 and
´10 regions are based on determination of the transcriptional start sites [19,51,55,61,62]. The ´35 box
is highly conserved in promoters of all genes while the ´10 box possesses greater variations.
The similarities and the functional conservations within the group V σ factors reinforce the idea
that the evolution of Clostridium species has been accompanied by the conserved use of a particular
type of σ factor that is distinct from the ECF group to transcribe toxin and bacteriocin genes in the
major pathogenic clostridia.
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4. Toxin Gene Transcription Is Negatively Controlled by TcdC
The inverse timing of the expression of tcdC and the other PaLoc genes [20] has long suggested
that TcdC could play a negative role in toxin gene expression. Moreover, the emergence of epidemic
strains that produce high levels of both toxins and carry deletions or frameshift mutations in the
tcdC gene reinforced the putative role of TcdC in the control of toxin production [17,63]. TcdC is
not similar to any known regulatory protein and lacks a DNA-binding motif [64]. TcdC is an acidic,
membrane-associated protein with a predicted molecular weight of 26 kDa [37,65]. This protein can
form dimers, which is consistent with the presence of a coiled-coil motif in the middle of TcdC [37].
These biochemical characteristics suggested that TcdC could regulate toxin gene transcription as an
anti-σ factor by modulating TcdR activity. Indeed, TcdC negatively regulates C. difficile toxin expression
by interfering with the ability of the TcdR-containing RNAP to recognize toxin gene promoters. Both
free TcdR and the preformed TcdR-containing holoenzyme were sensitive to TcdC activity. However,
once a stable open complex was formed with the tcdA promoter, TcdC could not prevent the binding of
the RNAP to the promoter [37], indicating that TcdC acts at the first stage of transcriptional initiation.
TcdC sequesters TcdR in the manner of classical anti-σ factors but also interacts directly with the core
RNAP, suggesting that TcdC may interfere with TcdR-dependent transcription via more than one
mechanism [37]. Interestingly, TcdC was shown to inhibit transcription in a manner dependent on
alternative σ factors, such as UviA and σW, which is an ECF sigma factor, but not on primary σA-type
factors [37], suggesting that the mode of action of TcdC is more dependent on the nature of the σ
factor than the core enzyme. Recently, van Leeuwen et al. [66] reported the ability of TcdC to bind
to DNA folded into G-quadruplex structures containing repetitive guanine nucleotides, generally
abundant in prokaryotic and eukaryotic gene promoters [67]. Thus, TcdC could also act by destabilizing
open complex formation before transcription initiation. However, no quadruplex-forming motif with
multiple G-stretches was found in the PaLoc raising the question of the relevance of such alternative
function of TcdC in the control of toxin genes transcription.
Although these in vitro experiments clearly established that TcdC interferes with the
TcdR-dependent transcription of toxin genes, recent in vivo studies generated contradictory results
concerning the importance of TcdC for toxin expression. For instance, mutations within the tcdC genes
are widespread among clinical isolates but cannot be used to predict the hyperproduction of toxins in
these strains [68–70]. However, none of these conclusions were drawn from the analysis of isogenic
C. difficile strains, which would be a prerequisite for clarifying the role of TcdC in vivo. Recently,
Carter et al. generated an isogenic strain by introducing a plasmid-borne copy of tcdC into a C. difficile
NAPI/027 strain (M7404) that lacks a functional tcdC gene. Those authors showed that the expression
of TcdC within the native host results in the down-regulation of toxin production and an attenuated
virulence phenotype in the hamster model of infection [71]. In contrast, another study showed that the
chromosomal complementation of another NAPI/027 strain (R20291) with a functional tcdC gene did
not change toxin titers [72] and that the disruption of the tcdC gene in the strain 630∆erm had little if
any effect on toxin production under the condition tested [72,73]. It was concluded in this study that
TcdC might have a moderate role in regulating toxin expression and that TcdC is therefore not a major
determinant of the hypervirulence of C. difficile. However, these studies did not exclude the possibility
that TcdC could exert a more profound effect under specific conditions or in other strains of C. difficile
than 630∆erm and NAPI/027. Whatever the reason, further work is needed to conclusively define the
role of TcdC in C. difficile and particularly on virulence capacity.
It has been clearly demonstrated that toxin synthesis is growth phase-dependent and regulated in
response to several environmental signals. Therefore, several other regulatory factors must be involved
in the control of toxin gene expression, either directly or indirectly through the modulation of TcdR
synthesis or TcdR activity, at least by interacting with TcdC.
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5. Toxin Expression Is Controlled by the Carbon Catabolite Repression (CCR) System
One of the most important groups of environmental cues that control toxin production is likely to
be nutritional signals, such as carbon sources or certain amino acids. Different combinations of carbon
sources that can be used by C. difficile to produce energy are available in culture media, which makes
difficult the study of the detailed role of a particular substrate on toxin formation. It is likely that
complex analysis to follow the temporal use and degradation pathways of the different carbon sources
would help to further our knowledge of the regulatory network controlling toxin production [74].
However, despite this limit, addition of single substrates in culture media led to the emergence of an
understanding of the associated regulatory mechanisms. The presence of glucose or other rapidly
metabolizable carbon sources in a complex growth medium represses toxin production independently
of the pH changes due to the glucose metabolism [19,22]. This glucose effect was observed in several
C. difficile strains, suggesting that a general mechanism might be involved in the control of toxin
production in response to glucose availability [19]. In addition, the repressive effect of glucose on
toxin synthesis occurred at the transcriptional level, which was consistent with the repression of tcdR
expression by glucose [50].
Most carbon sources that repress toxin gene expression are transported inside the bacterium by the
phosphoenolpyruvate-dependent carbohydrate: phosphotransferase system (PTS) [75]. This suggests
that the regulation of toxin gene transcription by these rapidly metabolizable carbon sources involves
carbon catabolite repression (CCR) [19]. The CCR allows bacteria to assimilate a preferred (e.g., rapidly
metabolizable) carbon source, such as glucose, when exposed to more than one carbohydrate in
the most profitable and economical way for the cell. In low G + C Gram-positive bacteria, the
main mechanism of the CCR is mediated by the pleiotropic regulator CcpA, which is a member of
the LacI/GalR repressor family. CcpA usually acts as a repressor of the utilization of alternative
carbon sources and as a positive regulator of pathways associated with glycolysis. Positive and
negative transcriptional control by CcpA involves the binding of this regulator to a cis-acting catabolite
responsive element (cre) that is located upstream or in the 51 part of the target genes. Moreover, the
DNA binding activity of CcpA to the cre sites is enhanced by its interaction with a component of
the PTS, the HPr protein. To activate CcpA, HPr must be phosphorylated at the regulatory residue
Ser-46 by the HPr kinase/phosphorylase (HPr-K/P) according to the intracellular concentration of
fructose-1-6-phosphate (FBP) [76–78]. Using C. difficile mutant strains defective in genes of the PTS or
in ccpA, it has been shown that both the uptake of glucose and the global regulator CcpA are required
for glucose-dependent repression of toxin genes [24]. In fact, only 50% of the glucose-regulated genes
are controlled by CcpA, whereas it is >80% in B. subtilis [79]. In C. difficile, the CcpA regulon includes
genes involved in sugar uptake, fermentation and amino acid metabolism, confirming the role of
CcpA as a link between carbon and nitrogen pathways and virulence gene expression in C. difficile.
CcpA mediates glucose-dependent repression of toxin production by interacting directly with the
promoter region or the 51 ends of several PaLoc genes, with the strongest affinity for the promoter
region of tcdR [79] (Figure 2). This observation is consistent with the presence of two cre sites upstream
of the transcriptional start of tcdR, whose sequence is significantly different from the consensus cre site
defined in Bacillus subtilis [79]. In addition, in contrast to FBP alone, neither HPr nor HPr-Ser-64-P
stimulated CcpA binding to its targets, which differs from the classical mode of action of CCR in
B. subtilis [24]. Interestingly, toxin production in the C. difficile ccpA mutant strain is constitutive with
respect to glucose but lower than that observed in the wild-type strain without glucose. This finding
indicates that other regulator(s) controlled by CcpA must contribute(s) to the regulation of toxin gene
expression independently of glucose. In C. perfringens, CcpA is known to regulate the expression of
enterotoxin (CPE) in a growth phase-dependent manner, which is not associated with the presence of
glucose [80]. Thus, it appears that the regulation of C. difficile toxin synthesis in response to glucose
availability is the result of a complex regulatory network in which CcpA plays a central role. Indeed,
CcpA controls directly or indirectly a large number of regulators [79] and participates with other global
regulators, such as CodY and Rex, in coordinating metabolism and virulence through the regulation of
Toxins 2016, 8, 153 7 of 24
fermentation processes that produce butyrate, which is known to stimulate toxin production (Figure 2
and see below). It was recently shown that glucose also repressed the synthesis of LCT by C. sordellii
and C. perfringens [43,44]. Both C. sordellii and C. perfringens encode CcpA homologs, but their role in
the glucose-dependent regulation of toxin production has not yet been demonstrated.Toxins 2016, 8, 153  7 of 23 
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Figure 2. Effects of regulatory proteins and etabolites on C. difficile toxin synthesis. The metabolites
that activate each regulatory protein is indicated: FBP, Fructose-1,6-bisphosphate; BCCAs, branch
chain amino acids (Isoleucine, Valine, Leucine); NAD, Nicotinamide adenine dinucleotide. Alternative
reductive pathways include glycine reductase (GR) pathway, butyrate production and succinate
utilization pathway. Square boxes correspond to alternative σ factors while oval boxes are
transcriptional regulators. Triangles are toxins. Arrowed lines indicate positive controls while lines
ending with a bar across correspond to negative controls. Dashed arrows indicate mechanisms that are
not fully understood.
6. Regulation of Toxin Synthesis in Response to Proline and Cysteine Availability
Proline and glycine have a powerful inhibitory effect on toxin production. The impact of both of
these amino acids on the C. difficile toxin yield [22] suggested a role for Stickland metabolism in the
control of toxin production. Like many Clostridium spp., C. difficile uses the Stickland reaction, which
involves the coupled oxidation and reduction of pairs of amino acids to generate ATP and NAD+. The
oxidative path way generates ATP and NADH, while the reductive pathway regenerates NAD+ from
NADH. Proline reductase (PR) and glycine reductase (GR) are specifically induced in the presence
of proline a d glycine, respectively, and carry out the respective reduction of these amino acids [81].
Mor over, the addition of proline to the g owth medium d reases the expression of the GR-en oding
genes, suggesting a prefe ential utilizati n of proline for NAD+ reg neration [26]. PrdR, whi h is
a regulator that res onds to proline, mediates both the proline-depend nt activation of PR and the
proline-dependent repression of toxin gen and the GR peron (Figur 2) [26]. However, nothing
is known regarding th m de of action of PrdR (direct or indirect) in the control of th PR, GR a d
toxin gene expression. The global effect of proline and PrdR on C. difficile gene expression was recently
studied via transcriptomic analyses and most of the proline-dependent effects on gene expression
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appeared to be mediated by PrdR. The genes whose expression was strongly affected are involved
in alternative pathways of NAD+ regeneration, such as GR, butyrate production and the succinate
utilization pathway, suggesting a hierarchical control of NAD+ regeneration [82]. Thus, when proline
is limiting in the medium or if PrdR or PR is inactive, the alternative reductive pathways are induced.
In fact, both PrdR and a functional PR are indirectly required for the proline-dependent regulation
of the alternative reductive pathways in response to the intracellular concentration of NADH and
NAD+. This process involves the global redox-sensing regulator Rex [82]. In several Gram-positive
bacteria, Rex acts as a repressor of genes that are important for growth using fermentation [83–88].
Rex directly senses changes in redox status and is only active as a DNA-binding protein when the
intracellular NADH/NAD+ ratio is low [84]. A Rex homolog is present in C. difficile, and putative Rex
boxes are identified upstream of PrdR-regulated genes, including those involved in the fermentation
pathways that produce butyryl-CoA from acetyl-CoA or succinate [89]. In a rex null mutant, the
addition of proline no longer represses these pathways. Moreover, the purified Rex protein can bind to
the respective genes, and the binding activity of Rex is stimulated by NAD+ but inhibited by NADH
(Figure 2) [82]. Although Rex, like PrdR, controls the proline-responsive expression of these alternative
reductive pathways, Rex also mediates the proline-dependent repression of toxin gene expression,
probably through the regulation of butyrate production. Consistent with this model, PrdR is active
and stimulates PR expression when proline is in excess. As a result, the NADH/NAD+ ratio is low
and Rex is active as a repressor of the alternative NAD+ regeneration pathways. In contrast, if proline
becomes limiting, the NADH/NAD+ ratio increases and NADH prevents Rex-dependent repression
of the alternative pathways. The regeneration of NAD+ using these alternative reductive pathways
leads to an accumulation of butyrate, a compound that stimulates toxin synthesis (Figure 2).
Cysteine is the most potent amino acid that down-regulates toxin production in both the reference
strain 630 and clinical isolates [23,25]. This sulfur-containing amino acid plays a central role in bacterial
physiology. Cysteine is a precursor of methionine and several co-enzymes, a sulfur donor for the
biogenesis of iron-sulfur clusters and is found in the catalytic sites of several enzymes. Links between
cysteine metabolism and bacterial virulence have been described in several pathogenic bacteria,
including C. perfringens and Bordetella pertussis [90,91]. To understand the molecular mechanism
involved in the cysteine-dependent repression of toxin production, a global transcriptomic analysis of
the genes controlled by cysteine was recently performed in C. difficile [92]. Genes that are regulated
in response to cysteine availability are involved in amino acid and energy metabolism, as well
as in fermentation pathways. It was initially demonstrated that cysteine does not regulate toxin
production by acting as a reducing agent [22]. Because cysteine metabolism during cell growth has an
impact on the pools of several metabolites, including carbon sources and amino acids, some global
regulators and σ factors, such as CcpA, CodY and σH, that are known to regulate toxin gene expression
were tested [24,93,94]. Among those factors, only σL, which belongs to the σ54 family and plays
an important role in the metabolism and virulence of Gram-positive bacteria [95,96], was shown
to mediate cysteine-dependent repression of toxin production (Figure 2) [92]. Because no σL-type
promoter was found upstream of toxin genes, it was hypothesized that σL regulates the PaLoc genes
indirectly, probably in response to by-products of cysteine degradation. This hypothesis was consistent
with the role of σL in the control of cysteine degradation in C. difficile. Moreover, the addition of the
first by-products of cysteine (pyruvate and sulfide) during cell growth decreased the transcription of
toxin genes and tcdR in both the wild-type and sigL mutant strains. In contrast, the addition of other
pyruvate by-products, such as formate and acetate, had no effect on PaLoc gene transcription [92].
Thus, pyruvate and sulfide, rather than cysteine, might be the main signals that modulate toxin
production (Figure 2). Further studies will be necessary to characterize the mechanism involved in
toxin production in response to cysteine by-products.
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7. Regulation of Toxin Synthesis by Nutritional Limitation Is Mediated by CodY
A strong link between nutrient limitation and toxin production came from the discovery that
the expression of all of the PaLoc genes is repressed by the global transcriptional regulator CodY,
which is involved in the adaptive response to nutrient sufficiency in the environment [93]. CodY is
highly conserved in low G + C content Gram-positive bacteria. In B. subtilis, during rapid growth,
CodY represses more than 100 genes whose products are not needed when nutrients are in excess and
releases this repression when nutrients become limited at the onset of stationary phase [97]. CodY
targets are associated with a range of adaptive behaviors, such as sugar and amino acid transport [97],
mobility [98] and sporulation [99]. In some pathogenic bacteria, CodY controls not only genes involved
in major physiological processes but also virulence factors [100]. CodY is a dimeric protein that binds
to DNA through a winged helix-turn-helix motif that is located in the C-terminal part of the protein.
The binding affinity of CodY for its target genes is increased in the presence of branched-chain amino
acids (isoleucine, leucine, and valine (BCAAs)) and GTP, either individually or in combination [99,101].
The presence of these cofactors is a signal of nutrient availability. Thus, when nutrients become
limiting, the intracellular levels of BCAAs and GTP are reduced, and CodY is no longer able to repress
genes involved in bacterial adaptation to starvation.
In C. difficile, more than 140 genes are under the control of CodY. Most of these genes are involved
in the biosynthesis of amino acids, nutrient transport fermentation pathways, sporulation and toxin
production [102]. Phenotype analysis of a C. difficile codY mutant showed that all of the PaLoc genes
are strongly derepressed during exponential phase [93], which is consistent with the higher level of
toxin produced in the codY mutant in comparison to the wild-type strain [82]. Indeed, CodY regulates
toxin gene expression by binding to the tcdR promoter region at three different locations with varying
affinities; two of these locations overlap with σ factor-binding regions [93]. Like in B. subtilis, GTP and
BCAA are co-factors of CodY in C. difficile (Figure 2) and exert independent and additive effects on the
in vitro activity of CodY [93]. This observation supported previous evidence that the presence of nine
amino acids in the medium, including BCAAs, significantly reduced C. difficile toxin synthesis [22].
Interestingly, CodY can interact with other regulatory networks in the control of both metabolic and
toxin genes. This type of interaction probably occurs through cyclic-di-GMP (c-di-GMP) signaling,
which is an important signal transduction system in the lifestyle of this pathogen (Figure 3). C-di GMP
is synthesized from 2 GTP molecules by diguanylate cyclases (DGCs) and degraded into pGpG or
2 GMP by phosphodiesterases (PDEs). The pool of c-di-GMP is controlled by a plethora of DGC and
PDE enzymes, and genes encoding several of these enzymes are controlled by CodY [102,103]. Thus,
changes in the intracellular concentration of GTP correlated with c-di-GMP synthesis can modify the
CodY activity. In addition, based on nutrient availability, CcpA can stimulate the production of BCAAs,
which are the second effector of CodY, illustrating that the regulatory pathways of CodY and CcpA are
intertwined. Finally, CodY, which directly represses PaLoc genes, can also contribute to the repression
of toxin synthesis by regulating the synthesis of butyrate (Figure 2). In fact, all enzyme-encoding genes
that are required for butyrate synthesis from acetyl-CoA and succinate are controlled by CodY in
response to the levels of BCAAs and GTP, as Rex responds to the NADH/NAD+ ratio (Figure 2).
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Figure 3. The regulatory net ork of the transition phase and the initiation of sporulation controlling
toxin production in C. difficile. The regulatory factors likely involved in quoru sensing are indicated
in purple and those involved in the response to the nutritional status of the cell are indicated in red.
Spo0A and its associated kinases (CD1579, CD1492, CD2492) are indicated in green. Square boxes
correspond to alternative σ factors while oval boxes are transcriptional regulators and diamond box
is enzyme. Arrowed lines indicate positive controls while lines ending with a bar across correspond
to negative controls. Dashed arrows indicate mechanisms that are not fully understood. AI-2 and
c-di-GMP mean auto-inducer 2 and cyclic di-guanosyl-51monophosphate.
8. The Regulatory Network That Controls Transition Phase, Sporulation and Toxin Production
in C. difficile
In vitro, toxin synthesis increases when the cells enter stationary phase [19], as was also observed
in vivo in the mouse model of CDI [104]. It was recently shown that toxin production is controlled
by regulators of the complex-regulatory network that is set up at the onset of stationary phase and
involved in the control of the initiation of sporulation [94,105–107]. The regulatory mechanisms
of the transition from exponential growth phase to stationary phase have been studied extensively
in B. subtilis [108], but differences exist in C. difficile [94,109,110]. The initiation of sporulation in
B. subtilis is controlled by a regulatory cascade (phosphorelay) that consists of five sensor kinases,
two intermediary phosphorylated proteins (Spo0B and Spo0F) and several phosphatases [111,112].
These proteins modulate the level of phosphorylation of the response regulator Spo0A in response to
nutrient availability, cell density and other signals. The phosphorylated form of Spo0A then activates
the transcription of several key sporulation genes. In addition, the alternative σ factor SigH, which is
involved in the transcription of major genes of the transition phase, is also required for the expression of
spo0A [113]. Both Spo0A and SigH are present in C. difficile, but orthologs of most of the phosphorelay
proteins, including Spo0B, Spo0F and the phosphatases, are missing. In the clostridia, the sporulation
initiation pathway is a two-component system with associated kinases that directly phosphorylate
Spo0A [114,115]. Three orphan histidine kinases are present in the C. difficile genome (CD1492, CD2492,
and CD1579) (Figure 3). CD1579 phosphorylates Spo0A in vitro, while the inactivation of CD2492
reduces the sporulation efficiency of the strain 630∆erm [110]. As observed in B. subtilis [113,116],
SigH and Spo0A of C. difficile regulate not only sporulation genes but also numerous genes that are
involved in several functions, such as metabolism, including the butyrate biosynthesis pathways,
cell wall metabolism, motility or encoding surface-associated proteins [94,105]. Moreover, SigH and
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Spo0A control toxin gene expression at the onset of stationary phase (Figure 3). In a sigH mutant,
the tcdA, tcdB and tcdR genes were overexpressed, implying that SigH represses toxin expression
through a mechanism that is likely indirect, as no SigH promoter has been found upstream of any
of the PaLoc genes [94]. Thus, SigH may act either by controlling the transcription of a gene that
encodes a repressor of toxin gene transcription or by competing with TcdR for interaction with the core
enzyme of the RNAP. The effect of spo0A inactivation on toxin production appears to be strain-specific.
Indeed, Spo0A represses toxin gene expression in some strains of ribotype 027 [106,107] but has no
or marginal effects in strains of ribotype 078 [106] and conflicting results have been reported for the
role of Spo0A on toxin production in 630∆erm [105–107,110,117]. In addition, none of the promoters
of the PaLoc genes contains a Spo0A binding sequence, suggesting that the effect of Spo0A on toxin
gene expression is indirect and needs to be characterized. Further work will be required to decipher
the molecular mechanisms that lead to the control of toxin production by Spo0A and SigH and to
identify the involved regulator(s) among those genes that are under the control of Spo0A and/or SigH
in transcriptomes [94,105].
Recently, a new regulator (RstA) that positively controls sporulation initiation and negatively
affects mobility and toxin production was identified [118]. RstA regulates toxin production and
mobility by repressing the transcription of SigD, the flagella-specific σ factor, which in turn directly
controls tcdR transcription (see below, Figure 3). RstA controls sporulation initiation through an
unidentified pathway, which is SigD-independent. This regulator belongs to the RNPP family of
transcriptional regulators involved in quorum sensing that includes PlcR, NprR and PrgX [119].
Moreover, RstA is conserved in pathogenic and non-pathogenic clostridia and closely related
organisms, suggesting that RstA is a key regulator protein that controls both sporulation and virulence
functions in these bacteria.
Reports that describe correlations between spore formation and toxin gene regulation in C. difficile
are contradictory [15,22,23,120]. In C. perfringens, sporulation and enterotoxin synthesis (Cpe) are
controlled by the mother cell-specific sigma factors SigE and SigK [121]. Indeed, the cpe gene
is specifically transcribed during sporulation from SigK- and SigE-dependent promoters, and its
expression was completely abolished in a sigE mutant [121,122]. In C. difficile, the sigH mutant is
unable to sporulate but still produces toxins. This finding indicated that sporulation is not required
for toxin synthesis and is instead a stationary-phase event. Consistent with this observation, no
transcriptional control of toxin genes by the four sporulation-specific sigma factors (SigF, SigE, SigG
and SigK) was observed in transcriptome analyses [123,124], and no toxins were detected in the
proteome of the spore [125] or the outer layers of the spore [126]. However, recent work using more
targeted approaches suggested that tcdA, tcdB and tcdR are expressed during sporulation [127]. Thus,
toxins might be produced not only at the onset of stationary phase after bacterial multiplication during
the colonization process [104] but also later during spore formation, leading to the production of spores
that contain toxins. Further work will be necessary to determine the extent to which toxinogenesis and
sporogenesis overlap and the impact of the possible relationship between these two processes that
play a central role in the C. difficile infectious cycle.
9. Other Regulators That Control Toxin Production
9.1. Toxin Gene Expression Is Controlled by Quorum Sensing
Quorum sensing (QS) is a cell density-dependent mechanism of gene expression control that
involves signaling molecules termed auto-inducers (AIs). Many virulence factors are produced by
bacterial pathogens at high cell density through quorum signaling systems. In Gram-positive bacteria,
these cell-cell communication systems involve peptides called autoinducing peptides (AIP), which act
as signaling molecules. In Staphylococcus aureus, the agr quorum-sensing locus agrACDB is involved
in controlling the expression of many secreted virulence factors during the transition phase [128].
The biosynthesis of AIP requires AgrD, which is the peptide precursor of AIP, and AgrB, which is a
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transmembrane endopeptidase involved in the processing and exportation of AIP. The accumulation
of extracellular concentrations of AIP activates a two-component system (TCS) by binding to the
sensor histidine kinase AgrC, which in turn modulates the activity of the response regulator AgrA.
All analyzed C. difficile genomes contain an incomplete agr- locus that contains agrDB and is named
the agr1 locus [129]. However, in addition to agr1, a complete agrACBD operon (agr2 locus) is present
in the genome of the C. difficile ribotype 027 isolate R20291 and in the genomes of some clinical
strains [129,130]. In strain R20291, the inactivation of agrA results in decreased toxin production
(Figure 3) and this mutant exhibits a colonization defect in mice [131,132]. Interestingly, AgrA also
controls flagellar synthesis and the expression of genes involved in c-di-GMP metabolism [132] that
are known to influence toxin gene expression, as indicated below. Thus, the Agr2 system appears to
play a role in C. difficile pathogenesis, at least in some lineages. In the 630 and R20291 backgrounds,
a thiolactone peptide that is likely synthesized by the agr1 locus is also involved in the induction of
toxin production [131]. The AgrD1 and AgrD2 prepeptides, which are encoded by the agr1 and agr2
loci, respectively, are 34% identical, but a cysteine residue that is probably involved in thioester bond
formation is only present in AgrD1. The TCS that senses AgrD1 remains to be identified. Interestingly,
an agrBD locus that is not linked to a TCS is also present in C. perfringens. This Agr system positively
controls the expression of various toxin genes in type A, B, C and D strains of C. perfringens [133–137].
In C. acetobutylicum, a complete agrBDCA cluster is involved in the cell density-dependent regulation
of granulose production and spore formation [138]. Two agrBD loci are also present in C. botulinum.
Both loci control sporulation and toxin production, with a more drastic effect on neurotoxin synthesis
for AgrD2 [139]. In C. difficile, further work will be needed to decipher the regulatory mechanisms
associated with the two Agr systems, to study the relationship between Agr1 and Agr2 and to
investigate the possible involvement of Agr1 in the control of sporulation.
In addition to the intra-species communication that is mediated by AIP in Gram-positive
bacteria, interspecies communication is also effective and involves a second class of QS molecules
(i.e., autoinducer-2 (AI-2)) that has been identified in several bacterial species [140]. The LuxS
enzyme, which forms part of the methyl cycle pathway, is involved in AI-2 synthesis from
S-ribosylhomocysteine [140,141]. Many pathogens, including C. difficile, have QS systems that detect
AI-2 and are involved in virulence expression. AI-2 up-regulates the expression of PaLoc genes
(tcdA, tcdB and tcdE) when added to the culture medium early during growth (Figure 3) [142]. However,
this effect is not observed in samples harvested after 24 h and 48 h of growth [143]. Interestingly, it
has been reported that a major catechin compound (Epigallocatechin gallate) isolated from green tea
downregulates LuxS production, leading to a decrease in the amount of AI-2 and lower expression of
the tcdA and tcdR genes [144]. In C. perfringens, LuxS/AI-2 also contributes to the regulation of α, κ
and θ toxin expression [145]. Further work will be necessary to decipher the molecular mechanisms
involved in the transient effect of AI-2 on toxin gene expression at the onset of stationary phase.
9.2. Control of Toxin Expression by c-di-GMP
The signaling molecule cyclic di-guanosyl-51monophosphate (c-di-GMP) is a second messenger
in bacterial systems and a key feature in the control of critical lifestyle choices, such as the transition
between planktonic and biofilm growth. Thus, elevated levels of c-di-GMP typically promote sessile
lifestyles, such as biofilm formation, while low levels of c-di-GMP are associated with motility [146].
In contrast to most Gram-positive bacteria, including some close relatives, C. difficile encodes a
large number of c-di-GMP turnover enzymes (18 predicted diguanylate cyclases and 19 predicted
phosphodiesterases), and enzymatic activity was confirmed for many of those enzymes [103,147].
In addition, 16 riboswitches that respond to c-di-GMP have been identified in C. difficile [148],
underlining the importance of c-di-GMP signaling in this human pathogen. In recent years, c-di-GMP
was found to regulate classical functions in C. difficile, including swimming and twitching motility,
adhesion, aggregation and biofilm formation [148–153]. Surprisingly, c-di-GMP was also shown to
affect toxin gene expression [154]. Indeed, artificial elevation of intracellular levels of c-di-GMP in
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C. difficile strongly represses the transcription of toxin-encoding genes and tcdR [154]. Interestingly, the
presence of high levels of c-di-GMP transcription also inhibited the expression of the gene encoding
the flagellar alternative σ factor SigD [154]. Moreover, in a sigD mutant, the expression of the tcdA,
tcdB and tcdR genes was reduced, and it was demonstrated that SigD directs the RNAP core enzyme to
recognize the tcdR promoter but not the tcdA and tcdB promoters [155]. Thus, the c-di-GMP-dependent
regulation of toxin expression is indirect and mediated by SigD, which is involved in tcdR transcription
and consequently in toxin synthesis (Figure 3).
9.3. Regulation of Toxin Expression by Flagellar Proteins
In addition to SigD, other flagellar components, such as the flagellin FliC and the capping protein
FliD, influence toxin production in C. difficile. In strain 630∆erm, the inactivation of fliC, which is a
late-stage flagellar regulon gene, led to increased expression of all Paloc genes except tcdC [156]. This
result was reinforced by another study that showed that the levels of tcdA transcripts are increased
in both fliC and fliD mutants in the same background [157]. Consistent with these data, the activity
of toxins in cell culture supernatants of fliC and fliD mutants was increased in comparison to the
parental strain. Moreover, these mutants were reported to be more virulent in hamsters in some but
not all studies [158]. In addition, toxin expression is not significantly altered in a strain lacking the
glycosyltransferase CD0240, which is an enzyme involved in FliC glycosylation [156]. The inactivation
of CD0240 resulted in cells that are non-motile, although unglycosylated FliC is still produced and
exposed at the cell surface [159]. Therefore, it appears that the loss of the flagellin FliC rather than a
non-functional flagellar filament affects toxin expression. It has been noted that the epidemic strain
R20291 produces only a single flagellum that is required for adherence to CaCo-2 cells, whereas strain
630∆erm is peritrichously flagellated, with flagella that contribute to overall fitness. Interestingly, in
contrast to strain 630∆erm, no change in cytotoxicity was observed between the R20291 wild-type
strain and the isogenic flagella mutants [157]. In addition, in vivo transcriptomic analysis performed at
14 h post-infection revealed that toxin transcription was not affected in a fliC mutant in comparison to
the R20291 wild-type strain. Thus, it appears that the influence of flagella on toxin production differs
depending on the C. difficile strain and is related to the structural components of the flagellum. More
work is needed to better understand the exact involvement of the flagellar regulon in toxin expression.
9.4. Impact of the Presence of Prophages on Toxin Gene Expression
Bacteriophages are the most abundant and diverse entities in the biosphere. Bacteriophages can
influence the abundance, diversity and evolution of bacterial communities [160]. Some lysogenic
phages can also modify the phenotypes of their hosts by encoding key virulence factors, such as the
diphtheria and botulinum toxins [161]. C. difficile has been shown to contain a number of different
bacteriophages [162], and the lysogenization of some of these bacteriophages has been shown to affect
toxin synthesis [163]. Indeed, it was shown that in the φCD119 or φCD27 lysogens derived from
C. difficile isolates, toxin production is repressed in comparison to the respective parental strains [164,
165]. In the case of φCD119, the expression of all PaLoc genes is downregulated in the lysogenic strain
in comparison to the parental strain, and this expression modulation involves the phage-encoded
protein RepR [164]. Furthermore, reporter gene fusion experiments and DNA binding studies showed
that RepR decreases toxin production indirectly by controlling the transcription of tcdR.
In contrast, the lysogenization of a ribotype 027 strain by φCD38-2 results in the stimulation
of toxin production [166]. In fact, in comparison to its parental strain, the level of toxin in a
φCD38-2 lysogenic strain was significantly increased in the culture supernatant but not in the cytosol.
Interestingly, the transcription of all PaLoc genes was higher in the φCD38-2 lysogen strain, but tcdE
appears to be expressed more strongly than the other genes of the PaLoc. The tcdE gene encodes a
protein that is similar to a class of bacteriophage proteins named holins that is required for the efficient
release of TcdA and TcdB from bacteria [38]. Together, these results suggested that the lysogenic strain
carrying φCD38-2 synthesizes and secretes more toxins than the parental strain due to the increased
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expression of PaLoc genes, especially tcdE. Further experiments will be necessary to understand how
the φCD38-2 can influence toxin gene expression. An increase in toxin production was also described
in other lysogens of C. difficile strains carrying the prophages ΦC2, ΦC6 and ΦC8. In these cases, the
effect likely relied on the modulation of toxin production or release rather than on the transcription of
tcdA and tcdB [167]. Thus, these reports raised the possibility that cross-talk between prophages and
bacterial genes exist in C. difficile, as illustrated by their impact on the PaLoc genes.
9.5. Links between the Stress Response and Toxin Gene Expression
The SOS regulatory network plays a central role in the bacterial response to DNA damage, which
is controlled by the global repressor LexA and an inducer, the recombinase RecA [168]. During normal
bacterial growth, LexA binds to the promoter region of the SOS genes and prevents their transcription.
Upon DNA damage, RecA polymerizes on single-stranded DNA that has formed at sites of DNA
damage and becomes activated. The activated form of RecA facilitates the inactivation of LexA via
self-cleavage, resulting in the expression of SOS genes [169]. In C. difficile strain R20291, the lexA
mutant exhibits alterations in cell division, motility, and sporulation and has a greater sensitivity
to metronidazole [170]. Moreover, LexA negatively controls biofilm formation. In the presence of
sub-inhibitory concentrations of levofloxacin, the production of TcdA but not TcdB increased in a
lexA mutant in comparison to the wild-type strain [170]. Levofloxacin is known to induce the SOS
response [171] and to repress toxin production in C. difficile [31,172]. Thus, these data suggested that
the inhibitory effect of levofloxacin on TcdA synthesis was countered by the constitutively induced
SOS response that is observed in the absence of LexA. Changes in the regulation of TcdA but not TcdB
in the lexA mutant are somehow consistent with the ability of LexA to bind only to the tcdA promoter
region, which contains a LexA binding motif [173]. Thus, LexA not only regulates DNA damage but
also controls other biological functions, including the regulation of toxin A production.
The transcription-repair coupling factor (Mfd in bacteria) is a highly conserved bacterial protein
that links the processes of nucleotide excision and transcription elongation [174]. In response to DNA
damage, Mfd removes RNA polymerase that is stalled at DNA lesions, increasing the rate at which
the lesions are repaired [175]. The removal of stalled RNAP is not confined to DNA lesions but also
occurs for RNAP that is stalled for other reasons, such as nucleotide starvation or blockage by other
DNA proteins, such as transcriptional repressors [176]. The inactivation of mfd in C. difficile resulted
in an unusual colony morphology and increased expression of TcdA and TcdB, which occurs at the
transcriptional level [177]. In B. subtilis, Mfd inactivation partially relieved the CodY- or CcpA-mediated
transcriptional repression of genes with binding sites downstream of the promoters [178–180]. Because
both CcpA and CodY binding sites have been identified downstream of the tcdR promoter [79,93], it is
possible that Mfd can affect the transcriptional regulation of toxin genes by relieving RNA polymerase
that is stalled at roadblocks created by CodY and/or CcpA, which are two major repressors of toxin
gene expression in C. difficile (Figure 3).
10. Conclusions
In the murine model, toxin synthesis occurs late during infection [104]. The complex regulation
of the C. difficile PaLoc genes that involves multiple environmental and physiological factors, suggests
that the bacterium’s strategy to persist and cause damage to the host is closely related to its nutritional
status. In response to transition phase, nutrient limitation and stresses, as well as the detection of cell
density through quorum sensing in the gastrointestinal tract during dysbiosis, the regulatory network
involved must contribute to trigger toxin production when needed. Particularly, the crucial role of the
control of toxin production in the response to nutrient limitation indicates that an intimate connection
exists between virulence and metabolism. Thus, the use by C. difficile of several global metabolic
regulators, such as CcpA, CodY, SigL, PrdR and Rex, to control toxin genes expression implies from
the bacterium‘s point of view that virulence is to a great extent a mechanism for improving nutrient
availability. Accordingly, such coordination is illustrated by the impact of butyrate on the regulation of
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toxin synthesis. Indeed, in addition to toxin synthesis, the major global regulators CodY and CcpA
control the expression of the alternative reductive pathways that regenerate NAD+ [24,93]. That is,
in response to FBP, CcpA activates the expression of the proline reductase gene cluster and represses
both the alternative NAD+-regenerating pathways that lead to butyryl-CoA and the genes (ptb and
buk) encoding enzymes that are used to convert butyryl CoA to butyrate [24]. These pathways are also
controlled by CodY in response to BCAAs and GTP [102]. Thus, when cells have an excess of NADH,
butyrate is produced suggesting that the stimulation of toxin synthesis by butyrate is a response to
the redox status of the cell (NADH/NAD+ ratio) and nutrient limitation (i.e., proline, BCAAs, and
carbohydrates). The molecular mechanism by which butyrate activates toxin synthesis remains to
be discovered. Interestingly, many inhabitants of the lower gastrointestinal tract produce butyrate,
while pyruvate, which down-regulates toxin production is apparently more abundant in the upper
part of the gut. This raises an interesting question about the role of both butyrate and pyruvate and
the mechanisms involved in the control of toxin synthesis along the intestinal tract in the context of
gut dysbiosis. Furthermore, the butyrate precursor butyril CoA, is also the precursor of butanol, an
inhibitor of toxin synthesis [25]. Thus, it would be interesting to know how the bacterium decides
to convert butyryl CoA into butanol or butyrate that would potentially help for the development of
novel therapeutics to reduce virulence. Finally, as virulence factors other than toxins become identified,
it will be also interesting to determine how they are controlled and to which environmental signals
they respond in order to better evaluate the extent to which C. difficile pathogenesis is influenced by
intracellular metabolite pools.
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